Works matching DE "VALSARTAN"
Results: 795
Preventing microalbuminuria with benazepril, valsartan, and benazepril-valsartan combination therapy in diabetic patients with high-normal albuminuria: A prospective, randomized, open-label, blinded endpoint (PROBE) study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Impact of clinical pharmacy guidance on valsartan recall management: a retrospective review.
- Published in:
- Drugs & Therapy Perspectives, 2022, v. 38, n. 6, p. 278, doi. 10.1007/s40267-022-00918-6
- By:
- Publication type:
- Article
Valsartan preconditioning protects against myocardial ischemia–reperfusion injury through TLR4/NF-κB signaling pathway.
- Published in:
- Molecular & Cellular Biochemistry, 2009, v. 330, n. 1/2, p. 39, doi. 10.1007/s11010-009-0098-1
- By:
- Publication type:
- Article
Acute Effects of Sacubitril/Valsartan with Initial Initiation in Pediatric Patients in the Cardiac Intensive Care Unit.
- Published in:
- Pediatric Cardiology, 2024, v. 45, n. 6, p. 1359, doi. 10.1007/s00246-023-03138-5
- By:
- Publication type:
- Article
From Other Journals.
- Published in:
- Pediatric Cardiology, 2013, v. 34, n. 5, p. 1296, doi. 10.1007/s00246-013-0719-z
- By:
- Publication type:
- Article
Sacubitril/valsartan compared to equivalent/sub-equivalent dose angiotensin receptor blocker or angiotensin-converting enzyme inhibitor in heart failure with reduced ejection fraction: a meta-analysis of randomized trials.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 8, p. 1113, doi. 10.1007/s00228-024-03686-6
- By:
- Publication type:
- Article
Effects of sacubitril/valsartan on exercise capacity: a prognostic improvement that starts during uptitration.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 9, p. 1173, doi. 10.1007/s00228-023-03527-y
- By:
- Publication type:
- Article
A collaborative study of the impact of N-nitrosamines presence and ARB recall on ARB utilization – results from IQVIA™ Disease Analyzer Germany.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 6, p. 849, doi. 10.1007/s00228-022-03439-3
- By:
- Publication type:
- Article
Association between the NEP rs701109 polymorphism and the clinical efficacy and safety of sacubitril/valsartan in Chinese patients with heart failure.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 5, p. 663, doi. 10.1007/s00228-023-03484-6
- By:
- Publication type:
- Article
Low- vs high-dose ARNI effects on clinical status, exercise performance and cardiac function in real-life HFrEF patients.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 1, p. 19, doi. 10.1007/s00228-021-03210-0
- By:
- Publication type:
- Article
Effect of SAcubitril/Valsartan on left vEntricular ejection fraction and on the potential indication for Implantable Cardioverter Defibrillator in primary prevention: the SAVE-ICD study.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 12, p. 1835, doi. 10.1007/s00228-021-03189-8
- By:
- Publication type:
- Article
A systematic approach for introduction of novel treatments to a chronic patient group: sacubitril-valsartan as a case study.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 1, p. 125, doi. 10.1007/s00228-020-02979-w
- By:
- Publication type:
- Article
Pharmacodynamic interaction between intravenous nitroglycerin and oral sacubitril/valsartan (LCZ696) in healthy subjects.
- Published in:
- European Journal of Clinical Pharmacology, 2018, v. 74, n. 9, p. 1121, doi. 10.1007/s00228-018-2509-2
- By:
- Publication type:
- Article
Repaglinide-irbesartan drug interaction: effects of SLCO1B1 polymorphism on repaglinide pharmacokinetics and pharmacodynamics in Chinese population.
- Published in:
- European Journal of Clinical Pharmacology, 2018, v. 74, n. 8, p. 1021, doi. 10.1007/s00228-018-2477-6
- By:
- Publication type:
- Article
Serious adverse drug reactions with sacubitril/valsartan Entresto®: a French pharmacovigilance survey.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Recent major advances in cardiovascular pharmacotherapy.
- Published in:
- European Journal of Clinical Pharmacology, 2018, v. 74, n. 7, p. 853, doi. 10.1007/s00228-018-2453-1
- By:
- Publication type:
- Article
Effect of renal function on the pharmacokinetics of LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor.
- Published in:
- European Journal of Clinical Pharmacology, 2016, v. 72, n. 9, p. 1065, doi. 10.1007/s00228-016-2072-7
- By:
- Publication type:
- Article
Single therapeutic and supratherapeutic doses of sacubitril/valsartan (LCZ696) do not affect cardiac repolarization.
- Published in:
- European Journal of Clinical Pharmacology, 2016, v. 72, n. 8, p. 917, doi. 10.1007/s00228-016-2062-9
- By:
- Publication type:
- Article
Adsorption of a Mixture of Daily Use Pharmaceuticals on Pristine and Aged Polypropylene Microplastics.
- Published in:
- Environments (2076-3298), 2024, v. 11, n. 9, p. 198, doi. 10.3390/environments11090198
- By:
- Publication type:
- Article
HEART FAILURE: AN OVERALL ASSESSMENT.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Safety and Tolerability of Antihypertensive Agents in Long-term: A Literature Review.
- Published in:
- KnE Life Sciences, 2024, p. 196, doi. 10.18502/kls.v8i2.17372
- By:
- Publication type:
- Article
Emperor-Preserved trial: what will change for patients with heart failure with preserved ejection fraction?
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Mechanisms of action of sacubitril/valsartan on cardiac remodeling: a systems biology approach.
- Published in:
- NPJ Systems Biology & Applications, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41540-017-0013-4
- By:
- Publication type:
- Article
The effects of valsartan treatment on visfatin levels and lipid profiles in newly diagnosed hypertensives.
- Published in:
- Turkish Journal of Medical Sciences, 2013, v. 43, n. 1, p. 57, doi. 10.3906/sag-1112-50
- By:
- Publication type:
- Article
Non-extractive spectrophotometric determination of valsartan in pure form and in pharmaceutical products by ion-pair complex formation with bromophenol blue and methyl red.
- Published in:
- Pharmacia (0428-0296), 2021, v. 68, n. 4, p. 851, doi. 10.3897/pharmacia.68.e73559
- By:
- Publication type:
- Article
Search for angiotensin II receptor antagonists among 4-aryl-n-(aryl)-3-(prop-2-en-1-yl)-2,3- dihydro-1,3-thiazol-2-imine derivatives.
- Published in:
- Pharmacia (0428-0296), 2019, v. 66, n. 4, p. 181, doi. 10.3897/pharmacia.66.e36808
- By:
- Publication type:
- Article
Retraction Note: Valsartan reduces AT1-AA-induced apoptosis through suppression oxidative stress mediated ER stress in endothelial progenitor cells.
- Published in:
- 2024
- Publication type:
- Correction Notice
Knowledge domain and emerging trends in sacubitril/valsartan study from 2008 to 2023 -- a visualized conclusive analysis based on novel scientometric tools.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2024, v. 28, n. 2, p. 502
- By:
- Publication type:
- Article
Empagliflozin and sacubitril/valsartan reverse methotrexate cardiotoxicity by repressing oxidative stress and hypoxia in heart embryonic H9c2 cardiomyocytes – the role of morphology of mitochondria observed on electron microscopy.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2023, v. 27, n. 9, p. 3979
- By:
- Publication type:
- Article
Clinical efficacy of enhanced external counter pulsation plus sacubitril/valsartan in the treatment of patients with chronic heart failure and the effect on ankle-arm index and cardiac function.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2023, v. 27, n. 8, p. 3300
- By:
- Publication type:
- Article
Author Correction: Impact of sacubitril/valsartan on implantable defibrillator eligibility in heart failure: a real-world experience.
- Published in:
- 2022
- Publication type:
- Correction Notice
Impact of sacubitril/valsartan on implantable defibrillator eligibility in heart failure: a real-world experience.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2021, v. 25, n. 18, p. 5690
- By:
- Publication type:
- Article
Valsartan improves cardiac function in mice with diabetes mellitus by CaMKII/AngII.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2018, v. 22, n. 16, p. 5327
- By:
- Publication type:
- Article
Valsartan reduces AT1-AA-induced apoptosis through suppression oxidative stress mediated ER stress in endothelial progenitor cells.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2017, v. 21, n. 5, p. 1159
- By:
- Publication type:
- Article
Valsartan attenuates cardiac and renal hypertrophy in rats with experimental cardiorenal syndrome possibly through down-regulating galectin-3 signaling.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2016, v. 20, n. 2, p. 345
- By:
- Publication type:
- Article
Clinical study of double dose of valsartan combined with tacrolimus in treatment of diabetic nephropathy.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2016, v. 20, n. 1, p. 174
- By:
- Publication type:
- Article
Photocatalytic Degradation of Valsartan by MoS 2 /BiOCl Heterojunctions.
- Published in:
- Catalysts (2073-4344), 2021, v. 11, n. 6, p. 650, doi. 10.3390/catal11060650
- By:
- Publication type:
- Article
Neprilysin inhibition with sacubitril/valsartan in the treatment of heart failure: mortality bang for your buck.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2016, v. 41, n. 2, p. 119, doi. 10.1111/jcpt.12363
- By:
- Publication type:
- Article
Parkinsonism and severe hypothyroidism in an elderly patient: a case of lithium toxicity due to pharmacological interactions.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2014, v. 39, n. 4, p. 452, doi. 10.1111/jcpt.12162
- By:
- Publication type:
- Article
Effect of telmisartan, valsartan and candesartan on mycophenolate mofetil pharmacokinetics in Japanese renal transplant recipients.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2009, v. 34, n. 6, p. 683, doi. 10.1111/j.1365-2710.2009.01053.x
- By:
- Publication type:
- Article
Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 5, p. 1177, doi. 10.1111/dom.13639
- By:
- Publication type:
- Article
Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 791, doi. 10.1111/dom.12877
- By:
- Publication type:
- Article
ARNI and SGLT2i: a promising association to be used with caution.
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
Long-term safety and tolerability of valsartan in children aged 6 to 17 years with hypertension.
- Published in:
- Pediatric Nephrology, 2019, v. 34, n. 3, p. 495, doi. 10.1007/s00467-018-4114-0
- By:
- Publication type:
- Article
Chart review of patients on valsartan-based single-pill combinations vs. ARB-based free combinations for BP goal achievement.
- Published in:
- Current Medical Research & Opinion, 2010, v. 26, n. 9, p. 2203, doi. 10.1185/03007995.2010.500883
- By:
- Publication type:
- Article
Efficacy and safety of a single-pill combination of amlodipine/valsartan in Asian hypertensive patients inadequately controlled with amlodipine monotherapy.
- Published in:
- Current Medical Research & Opinion, 2010, v. 26, n. 7, p. 1705, doi. 10.1185/03007995.2010.487391
- By:
- Publication type:
- Article
Economic evaluation of four angiotensin II receptor blockers in the treatment of hypertension.
- Published in:
- Current Medical Research & Opinion, 2010, v. 26, n. 6, p. 1307, doi. 10.1185/03007991003711045
- By:
- Publication type:
- Article
Comparison of the effects of nebivolol and valsartan on BP reduction and sleep apnoea activity in patients with essential hypertension and OSA.
- Published in:
- Current Medical Research & Opinion, 2010, v. 26, n. 8, p. 1925, doi. 10.1185/03007995.2010.497326
- By:
- Publication type:
- Article
Renal protective effect of RAAS blockade across the renal continuum, with a review of the efficacy and safety of valsartan.
- Published in:
- Current Medical Research & Opinion, 2009, v. 25, n. 12, p. 2933, doi. 10.1185/03007990903328231
- By:
- Publication type:
- Article
Efficacy and tolerability of amlodipine/valsartan combination therapy in hypertensive patients not adequately controlled on amlodipine monotherapy.
- Published in:
- Current Medical Research & Opinion, 2009, v. 25, n. 11, p. 2655, doi. 10.1185/03007990903251193
- By:
- Publication type:
- Article